The observational study on the safety of dexmedetomidine during endoscopic submucosal dissection for colorectal tumor

The observational study on the safety of dexmedetomidine during endoscopic submucosal dissection for colorectal tumor - The observational study on the safety of dexmedetomidine during endoscopic submucosal dissection for colorectal tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015786

Enrollment

Registered

2015-07-01

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will be performed ESD with colorectal tumor

Exclusion criteria

Exclusion criteria: Pregnant patients Patients with poor general condition Patients with serious cardiovascular or pulmonary disease, renal dysfunction and liver dysfunction.

Design outcomes

Primary

Measure	Time frame
Patient's circulation and Respiration during ESD for colorectal tumor	—

Secondary

Measure	Time frame
Evaluation of drug usage and sedation depth	—

Countries

Japan

Contacts

Public ContactHiroshi Oshima

Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology

h-oshima@med.nagoya-u.ac.jp052-744-2172

Outcome results